Author

Hetzel O. Diaz Tartera

Observed names: H O Diaz Tartera, H. O. Diaz Tartera, H. O. Diaz‐Tartera, H. Tartera Diaz, Hetzel Diaz, Hetzel Diaz-Tartera, Hetzel Olenia Diaz

Institution: Uppsala University

Observed institution: Uppsala University

ORCID: 0000-0001-7912-6324

Observed ORCID: 0000-0001-7912-6324

OpenAlex ID: A5014899720

Validation of SmartPill® wireless motility capsule for gastrointestinal transit time: Intra‐subject variability, software accuracy and comparison with video capsule endoscopy

2017 · H. O. Diaz Tartera, D.‐L. Webb, et al. · Neurogastroenterology & Motility · 82

Parallel Changes in Harvey-Bradshaw Index, TNFα, and Intestinal Fatty Acid Binding Protein in Response to Infliximab in Crohn’s Disease

2017 · Anas Kh. Al-Saffar, Carl Hampus Meijer, et al. · Gastroenterology Research and Practice · 81

PDF

Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy

2019 · Johanna Engström, Maria Lönnkvist, et al. · Scandinavian Journal of Gastroenterology · 13

PDF

Impact of biliopancreatic diversion with duodenal switch on glucose homeostasis and gut hormones and their correlations with appetite

2022 · Khalid Elias, Dominic-Luc Webb, et al. · Surgery for Obesity and Related Diseases · 12

PDF

Study of termination of postprandial gastric contractions in humans, dogs and Suncus murinus: role of motilin‐ and ghrelin‐induced strong contraction

2017 · T. Mikami, K. Ito, et al. · Acta Physiologica · 9

Differential Gastric Motility, Gut Hormone, and Appetite Changes Following A Mixed Meal in People With Obesity and Healthy Controls

2025 · Darius Javidi, Dominic‐Luc Webb, et al. · Neurogastroenterology & Motility · 3

PDF

Sa1990: GLUCAGON TWO YEARS AFTER BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH SURGERY FOR SEVERE OBESITY

2025 · Darius J. Javidi, Mohammad Abdul Halim, et al. · Gastroenterology

Mo2064: METABOLIC AND GUT HORMONE RESPONSES TO BARIATRIC SLEEVE GASTRECTOMY AND BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH.

2025 · Darius J. Javidi, Hetzel O. Diaz Tartera, et al. · Gastroenterology

Sa2041 INCRETIN EFFECT DURING A LOW-CALORIE MIXED BREAKFAST SMARTPILL® INVESTIGATION: TIMING OF POST-PRANDIAL METABOLIC HORMONE AND GLUCOSE CHANGES IN HEALTHY VOLUNTEERS

2024 · Darius Javidi, Mohammad Abdul Halim, et al. · Gastroenterology

Tu1594: GUT HORMONE, INSULIN RESISTANCE AND APPETITE PERCEPTION CHANGES FOLLOWING BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH

2022 · Khalid Elias, Dominic-Luc Webb, et al. · Gastroenterology

Untitled

2021 · Hetzel Diaz-Tartera, Per M Hellström · PubMed

Su128 HUNGER CONTRACTIONS DRIVING THE GASTRIC EMPTYING AS MEASURED BY WIRELESS MOTILITY CAPSULE (SMARTPILL®): HIGH CORRELATION WITH GHRELIN BUT NOT MOTILIN

2021 · moeen ud din, Hetzel O. Diaz Tartera, et al. · Gastroenterology

Su129 GASTRIC EMPTYING TIME AS MEASURED WITH WIRELESS MOTILITY CAPSULE (SMARTPILL) DISPLAYS HIGH CORRELATION TO HUNGER CONTRACTIONS AND PLASMA GHRELIN BUT NOT ACETAMINOPHEN OR GLUCOSE ABSORPTION, INSULIN OR GUT HORMONE RELEASE

2021 · moeen ud din, Hetzel O. Diaz Tartera, et al. · Gastroenterology

866 Concurrent Derangements in Transit Times and Meal Responses of Ghrelin, Motilin and Glp-1 in Myogenic and Neurogenic Chronic Intestinal Pseudo-obstruction

2021 · Dominic-Luc Webb, Anika T. Rahman, et al. · Gastroenterology

Mo1583 – Ghrelin and Motilin Derangements During Wireless Motility Capsule (Smartpill®) Recordings in Chronic Intestinal Pseudo-Obstruction

2019 · Dominic-Luc Webb, Hetzel O. Diaz Tartera, et al. · Gastroenterology

Gastrointestinal motility examined by wireless motility capsule (SmartPill®) and gut hormone profiles in inflammatory bowel diseases : Motility and hormones inIBD

2019 · Anas Al-Saffar, Hetzel Diaz, et al.

Sa1585 - Motility Defects in Chronic Intestinal Pseudo-Obstruction (Cipo) Detected by Wireless Motility Capsule

2018 · Dominic-Luc Webb, Hetzel O. Diaz Tartera, et al. · Gastroenterology

P407 Faecal calprotectin predicts sustained treatment response of infliximab induction therapy superior to C-reactive protein and clinical activity scores in inflammatory bowel disease

2018 · P M Hellström, M Lonnkvist, et al. · Journal of Crohn s and Colitis

Biomarkers Calprotectin and C-Reactive Protein Cut-Off Values Predict 52-Week Response to Infliximab Induction Therapy

2017 · Per M. Hellström, Hetzel Diaz · Gastroenterology

Smartpill Gastric Emptying Time Strongly Correlates with Last Hunger Contraction but not with Acetaminophen Absorption or Metabolic Parameters Plasma Glucose and Insulin

2017 · Hetzel O. Diaz Tartera, Per M. Hellström, et al. · Gastroenterology

P606 Intestinal fatty acid binding protein parallels temporal changes in Harvey-Bradshaw Index and TNFα in response to infliximab in Crohn's disease

2017 · P.M. Hellström, K.A. Al-Saffar, et al. · Journal of Crohn s and Colitis

[Motility-recording capsule simplifies gastrointestinal examination. Safe diagnostics in motility disorders].

2016 · Hetzel Diaz, Ulrika Sjöström, et al. · PubMed

Mo1301 Wireles Motility Capsule (SmartPill) in Healthy Volunteers: Normal Values of Transit, Reproducibility Over Time, Comparative Measures of Naked-Eye Readings vs Computerized Estimates, and Comparison With Capsule Endoscopy Camera

2015 · Per M. Hellström, Hetzel Diaz, et al. · Gastroenterology

PDF

Fecal calprotectin and serum C-reactive protein predict outcome of infliximab induction therapy in inflammatory bowel disease

2015 · Per M. Hellström, Hetzel Diaz, et al. · Journal of Crohns & Colitis

Works count: 24

Citation count: 200

H-index: 5

I10-index: 4